TY - GEN
T1 - SafeDrug
T2 - 30th International Joint Conference on Artificial Intelligence, IJCAI 2021
AU - Yang, Chaoqi
AU - Xiao, Cao
AU - Ma, Fenglong
AU - Glass, Lucas
AU - Sun, Jimeng
N1 - Publisher Copyright:
© 2021 International Joint Conferences on Artificial Intelligence. All rights reserved.
PY - 2021
Y1 - 2021
N2 - Medication recommendation is an essential task of AI for healthcare. Existing works focused on recommending drug combinations for patients with complex health conditions solely based on their electronic health records. Thus, they have the following limitations: (1) some important data such as drug molecule structures have not been utilized in the recommendation process. (2) drug-drug interactions (DDI) are modeled implicitly, which can lead to sub-optimal results. To address these limitations, we propose a DDI-controllable drug recommendation model named SafeDrug to leverage drugs' molecule structures and model DDIs explicitly. SafeDrug is equipped with a global message passing neural network (MPNN) module and a local bipartite learning module to fully encode the connectivity and functionality of drug molecules. SafeDrug also has a controllable loss function to control DDI level in the recommended drug combinations effectively. On a benchmark dataset, our SafeDrug is relatively shown to reduce DDI by 19.43% and improves 2.88% on Jaccard similarity between recommended and actually prescribed drug combinations over previous approaches. Moreover, SafeDrug also requires much fewer parameters than previous deep learning based approaches, leading to faster training by about 14% and around 2× speed-up in inference.
AB - Medication recommendation is an essential task of AI for healthcare. Existing works focused on recommending drug combinations for patients with complex health conditions solely based on their electronic health records. Thus, they have the following limitations: (1) some important data such as drug molecule structures have not been utilized in the recommendation process. (2) drug-drug interactions (DDI) are modeled implicitly, which can lead to sub-optimal results. To address these limitations, we propose a DDI-controllable drug recommendation model named SafeDrug to leverage drugs' molecule structures and model DDIs explicitly. SafeDrug is equipped with a global message passing neural network (MPNN) module and a local bipartite learning module to fully encode the connectivity and functionality of drug molecules. SafeDrug also has a controllable loss function to control DDI level in the recommended drug combinations effectively. On a benchmark dataset, our SafeDrug is relatively shown to reduce DDI by 19.43% and improves 2.88% on Jaccard similarity between recommended and actually prescribed drug combinations over previous approaches. Moreover, SafeDrug also requires much fewer parameters than previous deep learning based approaches, leading to faster training by about 14% and around 2× speed-up in inference.
UR - http://www.scopus.com/inward/record.url?scp=85125495098&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85125495098&partnerID=8YFLogxK
U2 - 10.24963/ijcai.2021/514
DO - 10.24963/ijcai.2021/514
M3 - Conference contribution
AN - SCOPUS:85125495098
T3 - IJCAI International Joint Conference on Artificial Intelligence
SP - 3735
EP - 3741
BT - Proceedings of the 30th International Joint Conference on Artificial Intelligence, IJCAI 2021
A2 - Zhou, Zhi-Hua
PB - International Joint Conferences on Artificial Intelligence
Y2 - 19 August 2021 through 27 August 2021
ER -